A case of a large cisterna magna cyst presented a problem in differential diagnosis. Characteristic changes were shown on plain skull roentgenograms and on radionuclide brain scan. The diagnosis was established on the basis of pneumoencephalography and isotope cisternography. The lesion responded well to surgical management.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/archneur.1979.00500420086013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intracisternal vs intraventricular injection of AAV1 result in comparable, widespread transduction of the dog brain.
Gene Ther
December 2024
Research Institute of Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Widespread distribution of transduced brain cells following delivery of AAV vectors into the cerebrospinal fluid (CSF) of the cisterna magna (CM) has been demonstrated in large animal brains. In humans, intraventricular injection is preferred to intracisternal injection for CSF delivery due to the risk of brain stem injury. One study in the dog reported adverse reactions to AAV vectors expressing GFP injected into the lateral ventricle but not when injected into the CM.
View Article and Find Full Text PDFSuboccipital Cisterna Magna Injection for Vehicle Delivery in Pigs Using Computed Tomography.
Curr Protoc
December 2024
Department of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas.
Gene therapies are being developed for several central nervous system (CNS) disorders. These therapies are primarily administered to the CNS via the cerebrospinal fluid (CSF), as the blood-brain barrier prevents the transport of large molecules to the brain. Currently, intrathecal injection is the most commonly used route of administration over cisterna magna injections in the clinic for gaining access to the CSF.
View Article and Find Full Text PDFIntra-cisterna-magna bevacizumab injection (ICM-BI) reproduces pathological alterations of cerebral small vessel diseases.
J Cereb Blood Flow Metab
October 2024
Department of Neurology, Mental and Neurological Disease Research Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
General modeling strategies for sporadic cerebral small blood vessel diseases (CSVDs) include limiting blood stream in large blood vessels and inducing systemic hypertension, in which small blood vessel deficit is either a secondary or concomitant pathology. In the current study, we introduce that intra-cisterna-magna Bevacizumab injection (ICM-BI) directly causes cerebral small blood vessel injury by neutralizing VEGF-A, the indispensable growth factor for angiogenesis. ICM-BI reproduces neuro-functional impairment, tight junction loss, cerebral micro-bleeds (CMBs), amyloid peptide accumulation, neuronal injury, white matter loss, and glial cell activation, which are common manifestations of sporadic CSVDs.
View Article and Find Full Text PDFSubarachnoid hemorrhage distinctively disrupts the glymphatic and meningeal lymphatic systems in beagles.
Theranostics
September 2024
Department of Neurosurgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Article Synopsis
- Subarachnoid hemorrhage (SAH) significantly impairs the glymphatic and meningeal lymphatic systems, leading to severe neurological and cognitive deficits in a beagle model, with blood clots, increased CSF pressure, and observable brain changes detected via MRI.
- The study included a daily cistern magna CSF drainage treatment from one to three days post-SAH to evaluate its effects on these systems' recovery.
- Findings showed that while initial lymphatic and glymphatic functions were disrupted, there was evidence of partial recovery by two weeks, highlighting the potential for targeted treatments in ameliorating the effects of SAH on brain health.
A minimally invasive endovascular approach to the cerebellopontine angle cistern enables broad CNS biodistribution of scAAV9-CB-GFP.
Mol Ther
October 2024
Horae Gene Therapy Center, UMass Chan Medical School, 368 Plantation Street, Worcester, MA 01605, USA; New England Center for Stroke Research, Department of Radiology, UMass Chan Medical School, 55 N Lake Avenue, Worcester, MA 01655, USA. Electronic address:
Neurological disorders pose a challenge for targeted therapy due to restricted access of therapeutic agents to the central nervous system (CNS). Current methods are limited by procedure-related risks, invasiveness, and insufficient CNS biodistribution. A novel percutaneous transvenous technology, currently in clinical trials for communicating hydrocephalus, offers a minimally invasive approach by providing endovascular access to the cerebrospinal fluid-filled cerebellopontine angle (CPA) cistern.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!